English
Japanese
COVID Hot topics
-
Omicron BF.7, the dominant subvariant in China COVID-19 outbreak
China // 22 December, 2022
BF.7, also known as BA.5.2.1.7...COVID-19
-
COVID-19 updates: cases of BF.7 reported
India // 22 December, 2022
At four new cases of COVID-19 with BF.7 variant...COVID-19
-
Additional COVID-19 booster doses for high-risk groups
South Africa // 21 December, 2022
Officials are considering an additional dose of COVID-19 vaccine for...COVID-19
-
Study finds surgical mask should not be worn over N95 mask
20 December, 2022
An N95 mask with an overlying procedure mask might lead to increased leakages...COVID-19
-
Eligibility for COVID-19 oral treatments updated
Australia // 06 December, 2022
Health authorities have updated the eligibility for oral treatments...COVID-19
-
COVID-19 vaccine approved for children six months and older
United Kingdom // 06 December, 2022
Recommendation by the Joint Committee on Vaccination and Immunisation still pending...COVID-19
-
Bebtelovimab, COVID-19 treatment no longer authorised by FDA
United States // 30 November, 2022
It is not expected to be effective against new dominants subvariants...COVID-19
-
WHO COVID-19 weekly reports November 2022
30 November, 2022
WHO updates on the global COVID-19 situation continue to show...COVID-19
-
Vaccine effectiveness against Omicron variant, WHO
24 November, 2022
Evidence based on 53 studies...COVID-19
-
Vaccine update - Administration of fourth dose has begun
Angola // 22 November, 2022
Fourth dose of COVID-19 vaccine starts...COVID-19
-
EMA authorises VidPrevtyn Beta COVID-19 vaccine, updates Spikevax clinical data
18 November, 2022
Both vaccines have been approved for use...COVID-19
-
COVID-19 cases rise
Brazil // 18 November, 2022
A rise in COVID-19 cases due to Omicron sub-variants BQ.1 and XBB ...COVID-19
-
Omicron variant BA.2 more likely to elicit symptoms
United Kingdom // 15 November, 2022
Study of over 1.5 million people…COVID-19
-
COVID-19 Vaccine Update – ATAGI updated recommendations on Pfizer bivalent booster dose in 18 years and older
Australia // 15 November, 2022
Updated recommendations for aged 18 years and above...COVID-19
-
COVID-19 variants- Cases of BN.1 increasing, BQ.1.1 and BQ.1 are now predominant
United States // 14 November, 2022
BA.5 cases are decreasing...COVID-19
-
COVID-19 Vaccine Update - Pfizer's BA.4/BA.5 bivalent vaccine to be used
South Korea // 14 November, 2022
Will be available from 14 November for people 18 and older...COVID-19
-
FDA authorises Kineret for the treatment of COVID-19
United States // 09 November, 2022
For use in hospitalised patients...COVID-19
-
Increase in COVID-19 cases caused by new Omicron subvariant XBB
Australia // 09 November, 2022
Health authorities have reported a rise in COVID-19 case numbers...COVID-19
-
ECDC Weekly COVID-19 report shows decreasing trend
04 November, 2022
Rates of cases and deaths continue to decrease but more detections of BQ.1 point to expected higher activity in the coming weeks...COVID-19
-
WHO COVID-19 weekly reports October 2022
02 November, 2022
WHO updates on the global COVID-19 situation continue to show...COVID-19
